4.9 (82) In stock
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint
ClearPoint Neuro, Inc.
Stock Market News 2022-04-28
FDA Clears Neurostimulation Device for Opioid Withdrawal Relief
Recent contributors: Duke, Sarah Cannon, and the UA Center for the Study of Tobacco and Society - The Cancer Letter
ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
ClearPoint Neuro Stock: Potential Inflection Point (NASDAQ:CLPT)
FDA Clears Turner Imaging Systems' Smart-C Mini C-arm
Initial Clinical Experience With ClearPoint SmartFrame Array–Aided Stereotactic Procedures - ScienceDirect
Neurosteer Announces FDA Clearance of the Neurosteer EEG Brain Monitoring Platform
ClearPoint Neuro Stock: Potential Inflection Point (NASDAQ:CLPT)
NDA for Diazepam Buccal Film Accepted by FDA for Seizure Cluster Treatment
ClearPoint Neuro, Inc. Announces First-in-Human Cases of
ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System
ETFs Holding CLPT, ClearPoint Neuro Inc
Medtronic acquires Ai Biomed Corp., receives FDA clearance for NIM Vital next-gen intraoperative nerve monitoring system – The Journal of Healthcare Contracting
